Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Journal Metrics
ESCI
Impact Factor
![](https://www.dovepress.com/cr_data/cache/journal_image/101/cope/thumb_100_1000_100.jpg)
Blood and Lymphatic Cancer: Targets and Therapy
ISSN: 1179-9889
Usage:
- 22,500 Annual downloads/views
Speed/ acceptance:
- 68 days average from submission to first editorial decision
- 8 days average from editorial acceptance to publication
- 20% acceptance rate
Citation metrics:
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
- 3.9 (2023) Impact Factor *
- 3.3 (2023) 5 year Impact Factor
- PubMed and PubMed Central (Blood Lymphat Cancer)
- Embase, from 2011
- Directory of Open Access Journals (DOAJ)
- The Open Access Initiative (OAIster)
*
- Emerging Sources Citation Index (ESCI)
For more details, please read our journal metrics summary.